Skip to main content
Cureus logoLink to Cureus
. 2023 Feb 2;15(2):e34563. doi: 10.7759/cureus.34563

Septic Olecranon Bursitis With Osteomyelitis Attributed to Cutibacterium acnes: Case Report and Literature Overview of the Dilemma of Potential Contaminants and False-Positives

John G Skedros 1,2,, Ethan D Finlinson 1, Meredith G Luczak 1, John T Cronin 1
Editors: Alexander Muacevic, John R Adler
PMCID: PMC9985484  PMID: 36879721

Abstract

We report an unusual case of acute septic olecranon bursitis, with probable olecranon osteomyelitis, where the only organism isolated in culture was initially considered a contaminant, Cutibacterium acnes. However, we ultimately considered it the likely causal organism when treatment for most of the other more likely organisms failed. This typically indolent organism is prevalent in pilosebaceous glands, which are scarce in the posterior elbow region. This case illustrates the often challenging empirical management of a musculoskeletal infection when the only organism isolated might be a contaminant, but successful eradication requires continued treatment as if it is the causal organism. The patient is a Caucasian 53-year-old male who presented to our clinic with a second episode of septic bursitis at the same location. Four years prior, he had septic olecranon bursitis from methicillin-sensitive Staphylococcus aureus that was treated uneventfully with one surgical debridement and a one-week course of antibiotics. In the current episode reported here, he sustained a minor abrasion. Cultures were obtained five separate times because of no growth and difficulty eradicating the infection. One culture grew C. acnes on day 21 of incubation; this long duration has been reported. The first several weeks of antibiotic treatment failed to eradicate the infection, which we ultimately attributed to inadequate treatment of C. acnes osteomyelitis. Although C. acnes has a well-known propensity for false-positive cultures as typically reported in post-operative shoulder infections, treatment for our patient’s olecranon bursitis/osteomyelitis was successful only after several surgical debridements and a prolonged course of intravenous and oral antibiotics that targeted it as the presumptive causal organism. However, it was possible that C. acnes was a contaminant/superinfection, and another organism was the culprit, such as a Streptococcus or Mycobacterium species that was eradicated by the treatment regime targeted for C. acnes.

Keywords: p. acnes, propionibacterium acnes, contaminants, false-positive, osteomyelitis, c. acnes, cutibacterium acnes, olecranon bursitis

Introduction

Orthopaedic surgeons and other healthcare providers who focus on musculoskeletal conditions are periodically faced with situations where there is clearly an infection, but the cultures fail to grow an organism or only show rare growth of an unlikely causal organism [1,2]. There are several explanations for this, including the administration of pre-culture antibiotics and inadequate culture media/conditions, especially for anaerobic biofilm-producing microorganisms [1,3,4]. In our shoulder and elbow reconstruction orthopaedic surgery practice we have become especially aware of the problem of negative or rare-growth cultures in deep infections of the shoulder region, especially after rotator cuff repairs and prosthetic arthroplasties [5-9]. Nearly 20 years ago when there was rare growth of an organism, such as a coagulase-negative Staphylococcus sp. or Cutibacterium acnes (formerly Propionibacterium acnes [10]) from deep tissue or fluid cultures obtained from post-operative shoulder infections it was often deemed a contaminant [5]. Empirical antibiotic treatment then ensued for a presumptive organism that failed to grow in culture. It was eventually realized that these more indolent organisms were the cause of some of these less-clear cases. Back then, surgeons needed to request that microbiology laboratories keep tissue cultures for 14 days so that these indolent organisms could be detected, especially for C. acnes. It is now routine protocol for microbiology laboratories to hold tissue cultures from bone and joint infections for 14 days, which is necessary to detect C. acnes [11]. However, sometimes up to 21 days is needed for this organism [12].

In the present case we were faced with a situation where, similar to confusing cases of post-operative shoulder infections, there was only the rare growth of an anaerobic/indolent biofilm-forming organism (C. acnes). C. acnes seemed to be a very unlikely cause of our patient’s acute septic olecranon bursitis with osteomyelitis because of the paucity of pilosebaceous glands, where C. acnes reside, in that region. There is only one reported case where C. acnes was considered a probable cause of septic olecranon bursitis, but that case also grew Staphylococcus epidermidis [13]. Hence, one of those organisms may have been a contaminant or superinfection. We report the present case of septic olecranon bursitis for three main reasons: (1) the rare growth of only C. acnes in culture, which was initially considered a contaminant but was eventually viewed as a likely cause of the infection, (2) to illustrate challenges in the treatment of a deep infection when it is unclear if the cultured organism is the cause of the infection or a contaminant/superinfection, and (3) show that successful treatment of a putative causal organism like C. acnes can also successfully treat other possible causal organisms that failed to grow in culture.

Case presentation

The patient is a 53-year-old right-hand-dominant male (height: 183 cm; weight: 84 kg; BMI: 25.13) who presented to our clinic with a chief complaint of pain and swelling at the posterior aspect of his right elbow. He did not have diabetes, denied illicit drug use, and did not have prior corticosteroid injections into his olecranon bursa. He smoked one pack of cigarettes and drank six or more beers each day. During his job installing fire sprinkler systems in commercial buildings, he would sustain abrasions on his elbows, forearms, and hands. Four years prior, an abrasion of his right elbow led to septic olecranon bursitis with methicillin-sensitive Staphylococcus aureus. This resolved after one surgical debridement and a one-week course of intravenous (IV) cephazolin and oral cephalexin. However, as a result of that debridement, he developed a painless scar adhesion between the skin and deeper tissues (Figure 1).

Figure 1. Patient's Posterior Elbow at 10 Months After Completing Antibiotic Treatment.

Figure 1

At the proximal aspect of the incision there is an asymptomatic adhesion (causing the obvious skin crease) stemming from the debridement surgery that was done four years prior. This image was taken in 20˚ of elbow flexion.

Prior to coming to our clinic for his second episode of septic olecranon bursitis, the patient’s primary care physician (PCP) empirically prescribed oral cephalexin 500mg four times a day and oral sulfamethoxazole/trimethoprim double strength twice a day; this treatment regime covered a broad spectrum of Staphylococcus and Streptococcus species that are common causes of septic olecranon bursitis [14]. No aspiration was done because there was no effusion. One week later, he was seen in our hospital emergency department (ED) (October 1, 2017) with worsening redness and progressive swelling of the posterior elbow region. Bloody fluid aspirated from the bursa was cultured. Blood tests showed normal values (basic metabolic analysis, white blood cell count [WBC], erythrocyte sedimentation rate [ESR], and C-reactive protein [CRP]). An additional 10-day course of the same oral antibiotics was prescribed. Five days later, his PCP aspirated bloody fluid from the olecranon bursa because of no growth from the ED culture. The patient continued the same antibiotic regimen. The PCP’s culture eventually grew C. acnes on day 21 (Table 1).

Table 1. Culture Dates, Incubation Times, Antibiotics, and Results.

* C = cephalexin; S/T = sulphamethoxazole/trimethoprim

Date of Culture Fluid or Tissue Days Held Antibiotics* Growth
Dec. 1, 2017 Fluid 14 C and S/T None
Dec. 6, 2017 Fluid 21 C and S/T C. acnes
Dec. 7, 2017 Tissue and Fluid 21 C and S/T None
Dec. 18, 2017 Tissue and Fluid 21 C and S/T None
Dec. 26, 2017 Tissue 21 vancomycin, levofloxacin, and rifampin None

At his first visit to our clinic (PCP culture was on day three), his olecranon bursa was moderately swollen and erythematous, but was not draining. The first irrigation and debridement procedure was then done using sterile technique. Through two 1.5-centimeter incisions, one at the proximal and one at the distal aspect of the bursa, 10 milliliters of seropurulent/phlegmonous material was drained. The inflamed bursa lining was scraped with a curette and the tissue was sent for aerobic and anaerobic bacterial, acid-fast bacilli (AFB/mycobacteria), and fungal cultures using the Isolator and BACTEC systems (Wampole Laboratories, Cranbury, NJ, USA; Becton Dickinson Diagnostic Instruments Systems, Sparks, MD, USA; [https://www.testmenu.com/Intermountain/TestDirectory/SiteFile?fileName=sidebar%5CWhichSwabForCulture-160622.pdf], accessed January 26, 2023). Irrigation was then done with 3% hydrogen peroxide, followed by saline, and then packing with an iodine-containing gauze strip. The current oral antibiotics were continued, reflecting our opinion that the missed aspect of his treatment was a debridement [15]. During the next 10 days, four debridements were done in the clinic and each included a sterile prep, gentle curettage of the bursa lining, and insertion of new sterile gauze packing strip. Although progressive improvement was seen, mild serous discharge persisted.

Because of continuing serous discharge and lack of growth from three prior cultures (ED, PCP, and ours) we again cultured the bursa lining (Table 1). MRI scanning revealed mild edema of the adjacent bone and marrow, suggesting early osteomyelitis (Figure 2). Consequently, daily oral levofloxacin 750mg and IV vancomycin were started (October 22, 2017) for broader coverage, as recommended by an infectious disease consultant [16]. Aspiration of the elbow joint yielded only a few drops of normal-appearing synovial fluid. After four days of this oral/IV antibiotic treatment, we performed a formal surgical irrigation and debridement with closure over a suction drain. Notably, none of the five debridements were deeper than the periosteum.

Figure 2. MR Images of Patient's Elbow.

Figure 2

Magnetic resonance (MR) T1-weighted images of our patient’s elbow in axial (A and B) and sagittal (C and D) views. Arrows point to increased signal in the olecranon, suggestive of early osteomyelitis. “H” indicates the condylar region of the humerus. Arthritis of the elbow joint, primarily of the olecranon articular surface, is also seen in the sagittal views.

All cultures obtained during the patient’s care were sent to the same laboratory. One culture was held for 14 days, all others were held for 21 days at the request of his surgeon (JGS) [11,17,18]. Our lab used fortified thioglycolate broth culture in anaerobic conditions. Because of the recalcitrant nature of the infection and growth of only C. acnes in culture, antibiotics were switched to IV ceftriaxone 2 grams daily and oral rifampin 300mg twice a day [19]. Despite improvement over the next three weeks, there was a 2mm region of the incision that had trace erythema with several drops of serous drainage per day. Consequently, our infectious disease consultant stopped oral rifampin and­­­ re-started IV vancomycin for an additional three weeks (ceftriaxone was also continued) for presumed osteomyelitis.

All antibiotics were stopped on December 31, 2017, and the infection was considered eradicated. However, two weeks later mild erythema and slight serous discharge recurred. Oral amoxicillin 500mg every six hours was then prescribed, which he took for three months [20,21]. We speculated that this extended course of oral antibiotics following IV antibiotics was the consequence of several factors, including (1) the ability of C. acnes or another anaerobic bacteria species to form a biofilm, (2) our patient’s immunocompromised state and poor healing capacity as a result of his alcoholism and smoking, (3) prior case of septic bursitis leaving subcutaneous scar tissue, and (4) bone involvement [22,23]. However, as discussed below, we also realized that other biofilm-forming organisms that failed to grow in culture might have been the causal organism and C. acnes was a contaminant/superinfection. No recurrence had occurred by his final follow-up 4.5 years later.

Discussion

C. acnes, commonly known for its role in acne, is an anaerobic Gram-positive bacterium skin commensal, especially in hair follicles (pilosebaceous glands) and the dermis [12,24]. In contrast to the posterior elbow where pilosebaceous glands are scarce, C. acnes is abundant in the shoulder region [25]. Consequently, there is ample literature with respect to the treatment of C. acnes infections in the settings of shoulder corticosteroid injections, rotator cuff repairs, and shoulder arthroplasties [5,18,26,27]. In these cases, penicillins (penicillin G and amoxicillin) and cephalosporins (cephalothin and ceftriaxone) have been shown to be effective in killing C. acnes [28]. Much can also be learned from shoulder surgery literature about C. acnes as a contaminant or false-positive organism in deep infections. For example, in a study on the incidence of C. acnes in open shoulder surgeries in cases that were not infected, Mook et al. [29] reported that 20.5% of surgeries (24 of 117) yielded at least one positive culture specimen. Notably, C. acnes represented 83% (39 of 47) of all positive cultures. They hypothesized that the unusually high prevalence of C. acnes infections reported in the shoulder surgery literature is likely due to cultures that are false-positive for infection. False-positive cultures might result from contamination during specimen collection, such as inadvertent inoculation of C. acnes from the skin, transport, incubation, or laboratory error [29]. From the perspective of these data, we initially assumed that C. acnes was a skin contaminant and that the organism that was the true cause of our patient’s infection was suppressed by the ongoing antibiotic treatment.

Because of our patient’s recalcitrant infection, we eventually viewed C. acnes as the likely cause, which was supported by its well-known propensity to form a biofilm in addition to being anaerobic. Few other organisms reported in cases of septic olecranon bursitis (Table 2; [13,23,30-51]) seemed more likely. It is possible that our patient’s infection was caused by a Streptococcus species, which are a relatively more common cause septic olecranon bursitis (Table 2), and C. acnes was a superinfection that was introduced during the multiple debridements [52,53]. A serum antistreptolysin O (ASO) titer would have helped detect Streptococcal species [54] but, unfortunately, this was not obtained from our patient. Additionally, despite the negative culture results, it is possible that other slow-growing atypical microbes, such as a Mycobacterium species, may have been the causative organism especially when considering that our patient was in an immunocompromised state from his alcoholism [31,34,51,55,56]. Many Streptococcus and Mycobacterium species also form biofilms and most of these species are also anaerobic [57-59]. The presence of such organisms may have been masked by the partial treatment that he received with levofloxacin and rifampin, thus explaining some response to these microbes followed by remission due to prolonged IV antibiotics. These possibilities further highlight the dilemma that clinicians may face when cultures show sole growth of an unlikely organism, and improvement in the infection is only seen when empirical treatment is continued for one or more putative causal organisms.

Table 2. Organisms Cultured from Bursitis Aspirates†.

† This table resembles the original published by Reilly and Kamineni [50], “Olecranon Bursitis”, pg. 162, copyright Elsevier; reproduced with permission. The original table has incorrectly numbered references, with most being off by one number. For example, if the actual reference was supposed to be no. 7, they indicated it as no. 8. In some cases, they list organisms that were not mentioned by the referenced study. For example, Weinstein et al. [47] or Wasserman et al. [48] (unclear which was intended) was listed as reporting Group A Streptococcus, but neither did.  

* Reilly and Kamineni did not distinguish between olecranon and other bursae. Consequently, it is also not clear which bursa is being referred to (e.g., olecranon or pre-patellar bursa) in some cases (indicated above with an asterisk). Although we attempted to focus on organisms cultured from olecranon bursae in our expansion of their Table, this was not always clear (like C. acnes in Pien et al. [34]). Note that we show Streptococcus pyogenes separate from Group A because that species was exactly specified in the three studies listed.

‡ This recent report describes Staphylococcus epidermidis and Propionibacterium acnes (C. acnes) as isolates from a case of olecranon bursitis/osteomyelitis [13].

Correction and Expansion of Table 1 in Reilly and Kamineni [50]
     Organism Reference
Gram-positive cocci  
     Staphylococcus aureus Most commonly found in most studies
     Staphylococcus epidermidis [13], [23]*, [30], [31]*, [32], [33]*, [34]*, [35], [36], [37]*
     Group A Streptococcus [23]*, [30], [31]*, [32], [33]*, [35], [37]*, [38], [39], [40]*, [44]
     Group B Streptococcus (includes S. agalactiae) [30], [31]*, [37]*
     Group C Streptococcus [35]
     Group G Streptococcus [36], [38], [40]*
     Streptococcus pyogenes [40]*, [41]*, [42]
     Strept. pneumoniae (& other α-hemolytic)                        [40]*, [43]
     Enterococcus faecalis [41]*
Gram-positive bacilli  
     Clostridium perfringens                       [44]
     Bacillus subtilis [23]*
Gram-negative bacilli  
     Acinetobacter anitratus  [34]*
     Klebsiella oxytoca [41]*
     Escherichia coli [31]*, [34]*
     Enterobacter cloacae [23]*, [34]*, [44]
     Serratia marcescens [45]
Gram-negative coccobacilli  
     Pseudomonas aeruginosa [31]*
     Pseudomonas fluorescens [23]*
     Haemophius influenzae (type b)         [44], [46]
Anaerobes  
     Brucella abortus [31]*
     Cutibacterium acnes [13], [34]*
Mycobacteria  
     Mycobacterium kansasii  [49]
     Mycobacterium tuberculosis [31]*
     Mycobacterium marinum [34]*
     Mycobacterium asiaticum [51]

For clinicians who face similar circumstances in a patient with septic olecranon bursitis where C. acnes is the only organism grown in culture, it is useful to consider the probability that it is the causal organism in the perspective of data showing that it is difficult to grow this organism in culture. The dilemma of rare-growth or no-growth cultures is now recognized as common in post-operative musculoskeletal infections, especially of artificial joints [1]. The incidence of negative cultures in this context ranges from 0 to 47% [1,60-65], with the highest percentage from non-arthroplasty shoulder surgeries [1]. A previous study focused specifically on olecranon and prepatellar septic bursitis, reported a culture-negative infection rate of nearly 30% [2]. In addition to being anaerobic, C. acnes grows slowly in culture for several reasons including the presence of a polymicrobial infection, culture media used, and other factors [11,17,18]. Because of this slow growth, C. acnes has potentially higher false-positive rates for long-hold specimens [6,29,66]. However, Bossard et al. [11] showed that reducing the culture time of C. acnes from 14 days to seven days increased the false-negative diagnostic rate by 21.4%. For the optimal recovery of C. acnes from surgical tissues, Hsu et al. [67] reviewed the literature and concluded that specimens should be cultured on multiple media, including aerobic, anaerobic, and broth, and should be observed for at least 17 days. Some studies suggest that cultures for C. acnes should be held up to 21 days [12], as was done in four of five cultures obtained in our case. In 51 non-infected patients that had cultures obtained at the time of shoulder arthroscopy, Chuang et al. [12] reported that they would have missed 34% of their positive cultures for C. acnes if the cultures were held for only 14 days. Some investigators now advise that a C. acnes infection should be diagnosed only when there are multiple positive cultures [17]. However, this recommendation is typically for establishing the presence of the causal organism in deep post-operative infections where a prosthesis or other orthopaedic hardware is present. But when there is no prosthesis/hardware and multiple cultures are not taken at the same time (as in our case), the rare growth of a prevalent commensal organism like C. acnes poses a dilemma.

We did not pause our patient’s antibiotic treatment so that cultures could be grown without the suppression of antibiotics. Current methods that can help to distinguish between contamination and true infection include obtaining multiple cultures at the same time, histopathological analysis, distinguishing single bacterial cells from biofilm-related infections by immunofluorescence microscopy, investigation of the ability of C. acnes isolates to form a biofilm, and other emerging methodologies [68,69]. Osteomyelitis in the adjacent bone has been reported as a complication of septic olecranon and pre-patellar bursitis [13,30,31,44,70]. In our patient, the C. acnes and/or another organism that failed to grow in culture might have been introduced by a deep puncture/abrasion. Microscopic spread of the organisms might be caused by cell division and/or the intracellular invasion of marrow mesenchymal stem cells, which is a known behavior of C. acnes [71]. This type of spread may have been more likely in our patient since the skin over his olecranon was adherent to the underlying tissues, suggesting a more direct path from skin to bone (Figure 1). Hence, the bone itself may have become the reservoir of biofilm-encased C. acnes that caused our patient’s recalcitrant septic olecranon bursitis. However, C. acnes osteomyelitis is rare [72,73]. Therefore, in the treatment of our patient it would seem prudent to debride and culture the bone as well. However, given that our patient was a manual laborer who was concerned about returning to work quickly and the possibility of further surgery for muscle flap coverage of the debrided bone [74,75], we opted to avoid debridement of the olecranon. After our patient successfully cleared his infection, it became clear to us that there have been reports of septic olecranon bursitis with osteomyelitis that utilized bone debridement without subsequent plastic surgery intervention for wound coverage (e.g., no muscle flap was required) [76,77]. Therefore, physicians who are faced with similar circumstances should consider more aggressive debridement than what was done in this present case.

Because C. acnes was the only organism grown in culture, the possibility that it was the causal organism of our patient’s olecranon bursitis/osteomyelitis warrants additional critical consideration in the context of other possible causal organisms. There are C. acnes strains that are invasive and others that are not; the latter are usually studied [68,78]. C. acnes is also known to cause osteomyelitis as a complication of implanted orthopaedic hardware [20,71,79-81]. Notably, some Mycobacterial and Streptococcal strains can also be locally invasive and cause osteomyelitis [55,82-84]. Though the prevalence of C. acnes as the cause of osteomyelitis is not known, results of a study by Asseray et al. [80] further illustrate the rarity of our patient’s case. These investigators conducted a retrospective study with the aim of developing a diagnostic strategy to distinguish C. acnes infections from other bacterial contamination. Their cohort included all patients hospitalized between 2000 and 2004 in an orthopaedic surgery unit who had a deep sample positive for C. acnes from the pelvis (15% of cases), spine (40%), lower limb (12%), shoulder (22%), and other upper limb (11%) (the elbow was not specified). Although 65 patients had cultures positive for C. acnes, only 52 (80%) were considered to have a true infection. Of those 52 patients and unlike our patient, 48 had an implanted orthopaedic device, likely reflecting a thicker or otherwise modified C. acnes biofilm in association with the metal [71,85]. We could not locate another case where septic olecranon bursitis with osteomyelitis was possibly caused only by C. acnes. Septic bursitis due to C. acnes has been reported in other bursae, such as the iliopectineal bursa [86]. Prior reports of septic olecranon bursitis attributed to C. acnes are almost always inaccurately or imprecisely referenced (Table 2). For example, Pien et al. [34] reported a case of C. acnes bursitis, but they did not report and could not recall if their patient had olecranon or pre-patellar bursitis (personal communication, Dr. Francis Pien). Furthermore, they did not provide details of the patient’s characteristics, potential cause, or treatment rendered. The only other case that reported C. acnes olecranon bursitis was polymicrobial [13].

Staphylococcus aureus and some Streptococcus species are common cases of septic olecranon bursitis (Table 2). Other reported organisms are shown in Table 2, which is patterned after Reilly and Kamineni [50]. Notably, their table contains multiple errors, which we have corrected (see footnote to Table 2). Septic olecranon bursitis is usually a bacterial infection caused by skin lesions or by secondary spread from initial cellulitis into a pre-traumatized superficial bursa [87]. Factors that increase the risk of acquired septic olecranon bursitis are persistent pressure on the bursa due to work demands, corticosteroid therapy, rheumatoid arthritis, lupus, gout, and other conditions that reduce immunity. Alcoholics have a higher incidence of septic olecranon bursitis due to their higher risk of trauma and immunosuppression [39,50,88]. Similarly, smoking increases the chances of olecranon bursitis and generally slows wound healing [89,90]. Eradication of olecranon bursitis can take three times longer in immunocompromised patients [39,91].

Our patient had prior surgery for an infection in the same location, which caused a subcutaneous adhesion at the upper aspect of the olecranon bursa region (Figure 1). In addition to his alcoholism and current smoking habit, we suggest that this adhesion and additional scar tissue along the incision of the prior debridement surgery resulted in reduced perfusion, potentially impairing immunity and impeding adequate antibiotic tissue levels. Asseray et al. [80] report an increased likelihood of infection in cases with prior surgery in the same area. In a comprehensive review of septic bursitis in anatomical locations, Zimmerman et al. [44] provide an illustrative case and also state that a previous septic olecranon bursitis can increase the likelihood of developing a subsequent septic olecranon bursitis.

Conclusions

Although C. acnes has a well-known propensity for false-positive cultures as typically reported in post-operative shoulder infections, treatment for our patient’s septic olecranon bursitis/osteomyelitis was successful only after several surgical debridements and a prolonged course of IV and oral antibiotics that targeted it as the presumptive causal organism. However, it was still possible that C. acnes was a contaminant/superinfection, and another organism was the culprit, such as a Streptococcus or Mycobacterium species, which was eradicated by the treatment regime targeted for C. acnes. The infection was successfully eradicated with IV antibiotics and an extended course of oral antibiotics. We speculated that this extended course of oral antibiotics following IV antibiotics reflected the ability of C. acnes or another anaerobic bacteria species to form a biofilm, our patient’s immunocompromised state and impaired healing capacity resulting from alcoholism and smoking, his prior case of septic bursitis leaving subcutaneous scar tissue, and bone involvement. This case illustrates the often challenging empirical management of a musculoskeletal infection when the only organism isolated is C. acnes, which might be a contaminant but successful eradication requires continued treatment as if it is the causal organism.

The content published in Cureus is the result of clinical experience and/or research by independent individuals or organizations. Cureus is not responsible for the scientific accuracy or reliability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. Additionally, articles published within Cureus should not be deemed a suitable substitute for the advice of a qualified health care professional. Do not disregard or avoid professional medical advice due to content published within Cureus.

The authors have declared that no competing interests exist.

Human Ethics

Consent was obtained or waived by all participants in this study

References

  • 1.Shoulder joint infections with negative culture results: clinical characteristics and treatment outcomes. Abdou MA, Jo A, Choi IS, et al. Biomed Res Int. 2019;2019:3756939. doi: 10.1155/2019/3756939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Clinical characteristics and management of olecranon and prepatellar septic bursitis in a multicentre study. Charret L, Bart G, Hoppe E, et al. J Antimicrob Chemother. 2021;76:3029–3032. doi: 10.1093/jac/dkab265. [DOI] [PubMed] [Google Scholar]
  • 3.The diagnosis of prosthetic joint infection: current techniques and emerging technologies. Patel R, Osmon DR, Hanssen AD. Clin Orthop Relat Res. 2005:55–58. doi: 10.1097/01.blo.0000175121.73675.fd. [DOI] [PubMed] [Google Scholar]
  • 4.Sonication of explanted prosthetic components in bags for diagnosis of prosthetic joint infection is associated with risk of contamination. Trampuz A, Piper KE, Hanssen AD, Osmon DR, Cockerill FR, Steckelberg JM, Patel R. J Clin Microbiol. 2006;44:628–631. doi: 10.1128/JCM.44.2.628-631.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Infection after mini-open rotator cuff repair. Herrera MF, Bauer G, Reynolds F, Wilk RM, Bigliani LU, Levine WN. J Shoulder Elbow Surg. 2002;11:605–608. doi: 10.1067/mse.2002.127302. [DOI] [PubMed] [Google Scholar]
  • 6.Propionibacterium acnes infection after shoulder arthroplasty: a diagnostic challenge. Dodson CC, Craig EV, Cordasco FA, et al. J Shoulder Elbow Surg. 2010;19:303–307. doi: 10.1016/j.jse.2009.07.065. [DOI] [PubMed] [Google Scholar]
  • 7.Propionibacterium spp. in prosthetic joint infections: a diagnostic challenge. Zappe B, Graf S, Ochsner PE, Zimmerli W, Sendi P. Arch Orthop Trauma Surg. 2008;128:1039–1046. doi: 10.1007/s00402-007-0454-0. [DOI] [PubMed] [Google Scholar]
  • 8.Propionibacterium acnes in shoulder surgery: true infection, contamination, or commensal of the deep tissue? Hudek R, Sommer F, Kerwat M, Abdelkawi AF, Loos F, Gohlke F. J Shoulder Elbow Surg. 2014;23:1763–1771. doi: 10.1016/j.jse.2014.05.024. [DOI] [PubMed] [Google Scholar]
  • 9.Reply: Low-grade Cutibacterium acnes shoulder infections do exist!: In response to the Letter to the Editor by Reinier WA Spek, Job N Doornberg, David Ring and Michel PJ van den Bekerom. Dorrestijn O, Pruijn N. Shoulder Elbow. 2021;13:151–153. doi: 10.1177/1758573220979906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.The natural history of cutaneous propionibacteria, and reclassification of selected species within the genus Propionibacterium to the proposed novel genera Acidipropionibacterium gen. nov., Cutibacterium gen. nov. and Pseudopropionibacterium gen. nov. Scholz CF, Kilian M. Int J Syst Evol Microbiol. 2016;66:4422–4432. doi: 10.1099/ijsem.0.001367. [DOI] [PubMed] [Google Scholar]
  • 11.Optimal length of cultivation time for isolation of Propionibacterium acnes in suspected bone and joint infections is more than 7 days. Bossard DA, Ledergerber B, Zingg PO, Gerber C, Zinkernagel AS, Zbinden R, Achermann Y. J Clin Microbiol. 2016;54:3043–3049. doi: 10.1128/JCM.01435-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.The Incidence of Propionibacterium acnes in Shoulder Arthroscopy. Chuang MJ, Jancosko JJ, Mendoza V, Nottage WM. Arthroscopy. 2015;31:1702–1707. doi: 10.1016/j.arthro.2015.01.029. [DOI] [PubMed] [Google Scholar]
  • 13.Propionibacterium acnes and Staphylococcus epidermidis olecranon bursitis/osteomyelitis: a case involving surgical and antibiotic treatment. Skedros JG, Adondakis MG, Brown EM, Oliver MR. BMJ Case Rep. 2018;2018 doi: 10.1136/bcr-2017-223782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Hersh AL, Chambers HF, Maselli JH, Gonzales R. Arch Intern Med. 2008;168:1585–1591. doi: 10.1001/archinte.168.14.1585. [DOI] [PubMed] [Google Scholar]
  • 15.Cutibacterium acnes prosthetic joint infection: diagnosis and treatment. Boisrenoult P. Orthop Traumatol Surg Res. 2018;104:0–24. doi: 10.1016/j.otsr.2017.05.030. [DOI] [PubMed] [Google Scholar]
  • 16.Comparative in vitro activities of dalbavancin and seven comparator agents against 41 Staphylococcus species cultured from osteomyelitis infections and 18 VISA and hVISA strains. Citron DM, Tyrrell KL, Goldstein EJ. Diagn Microbiol Infect Dis. 2014;79:438–440. doi: 10.1016/j.diagmicrobio.2014.05.014. [DOI] [PubMed] [Google Scholar]
  • 17.Optimization of periprosthetic culture for diagnosis of Propionibacterium acnes prosthetic joint infection. Butler-Wu SM, Burns EM, Pottinger PS, Magaret AS, Rakeman JL, Matsen FA 3rd, Cookson BT. J Clin Microbiol. 2011;49:2490–2495. doi: 10.1128/JCM.00450-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Low-grade infections in nonarthroplasty shoulder surgery. Khan U, Torrance E, Townsend R, Davies S, Mackenzie T, Funk L. J Shoulder Elbow Surg. 2017;26:1553–1561. doi: 10.1016/j.jse.2017.01.008. [DOI] [PubMed] [Google Scholar]
  • 19.Role of rifampin against Propionibacterium acnes biofilm in vitro and in an experimental foreign-body infection model. Furustrand Tafin U, Corvec S, Betrisey B, Zimmerli W, Trampuz A. Antimicrob Agents Chemother. 2012;56:1885–1891. doi: 10.1128/AAC.05552-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Propionibacterium acnes infection of the elbow. Jones M, Kishore MK, Redfern D. J Shoulder Elbow Surg. 2011;20:0–5. doi: 10.1016/j.jse.2011.02.016. [DOI] [PubMed] [Google Scholar]
  • 21.Treatment of prosthetic joint infections due to Propionibacterium. Similar results in 60 patients treated with and without rifampicin. Jacobs AM, Van Hooff ML, Meis JF, Vos F, Goosen JH. Acta Orthop. 2016;87:60–66. doi: 10.3109/17453674.2015.1094613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Inadvisable treatment of recalcitrant septic olecranon bursitis: an unusual case of extremely prolonged treatment with oral antibiotics after bursectomy. Pitts TC, Kiser CJ, Skedros JG. https://www.journalmc.org/index.php/JMC/article/view/463/298 J Med Cases. 2012;3:100–105. [Google Scholar]
  • 23.Septic bursitis: presentation, treatment and prognosis. Raddatz DA, Hoffman GS, Franck WA. https://pubmed.ncbi.nlm.nih.gov/3437425/ J Rheumatol. 1987;14:1160–1163. [PubMed] [Google Scholar]
  • 24.Propionibacterium acnes colonization of the human shoulder. Patel A, Calfee RP, Plante M, Fischer SA, Green A. J Shoulder Elbow Surg. 2009;18:897–902. doi: 10.1016/j.jse.2009.01.023. [DOI] [PubMed] [Google Scholar]
  • 25.The human skin microbiome. Byrd AL, Belkaid Y, Segre JA. Nat Rev Microbiol. 2018;16:143–155. doi: 10.1038/nrmicro.2017.157. [DOI] [PubMed] [Google Scholar]
  • 26.Deep infection after rotator cuff repair. Athwal GS, Sperling JW, Rispoli DM, Cofield RH. J Shoulder Elbow Surg. 2007;16:306–311. doi: 10.1016/j.jse.2006.05.013. [DOI] [PubMed] [Google Scholar]
  • 27.Injection-induced low-grade infection of the shoulder joint: preliminary results. Schneeberger AG, Yian E, Steens W. Arch Orthop Trauma Surg. 2012;132:1387–1392. doi: 10.1007/s00402-012-1562-z. [DOI] [PubMed] [Google Scholar]
  • 28.Antimicrobial susceptibility of Propionibacterium acnes isolates from shoulder surgery. Crane JK, Hohman DW, Nodzo SR, Duquin TR. Antimicrob Agents Chemother. 2013;57:3424–3426. doi: 10.1128/AAC.00463-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.The incidence of Propionibacterium acnes in open shoulder surgery: a controlled diagnostic study. Mook WR, Klement MR, Green CL, Hazen KC, Garrigues GE. J Bone Joint Surg Am. 2015;97:957–963. doi: 10.2106/JBJS.N.00784. [DOI] [PubMed] [Google Scholar]
  • 30.Septic subcutaneous bursitis. Report of sixteen cases. Canoso JJ, Sheckman PR. https://europepmc.org/article/med/439118. J Rheumatol. 1979;6:96–102. [PubMed] [Google Scholar]
  • 31.The clinical spectrum of severe septic bursitis in northwestern Spain: a 10 year study. Garcia-Porrua C, Gonzalez-Gay MA, Ibanez D, Garcia-Pais MJ. https://europepmc.org/article/med/10090179. J Rheumatol. 1999;26:663–667. [PubMed] [Google Scholar]
  • 32.Antibiotic therapy of septic bursitis. Its implication in the treatment of septic arthritis. Ho G Jr, Su EY. Arthritis Rheum. 1981;24:905–911. doi: 10.1002/art.1780240707. [DOI] [PubMed] [Google Scholar]
  • 33.Treatment of septic olecranon and prepatellar bursitis with percutaneous placement of a suction-irrigation system. A report of 12 cases. Knight JM, Thomas JC, Maurer RC. https://journals.lww.com/clinorthop/Abstract/1986/05000/Treatment_of_Septic_Olecranon_and_Prepatellar.18.aspx. Clin Orthop Relat Res. 1986:90–93. [PubMed] [Google Scholar]
  • 34.Septic bursitis: experience in a community practice. Pien FD, Ching D, Kim E. Orthopedics. 1991;14:981–984. doi: 10.3928/0147-7447-19910901-09. [DOI] [PubMed] [Google Scholar]
  • 35.Septic and nonseptic olecranon bursitis. Utility of the surface temperature probe in the early differentiation of septic and nonseptic cases. Smith DL, McAfee JH, Lucas LM, Kumar KL, Romney DM. Arch Intern Med. 1989;149:1581–1585. doi: 10.1001/archinte.149.7.1581. [DOI] [PubMed] [Google Scholar]
  • 36.Management of acute bursitis: outcome study of a structured approach. Stell IM. J R Soc Med. 1999;92:516–521. doi: 10.1177/014107689909201006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Reaction of superficial bursae in response to specific disease stimuli. Canoso JJ, Yood RA. Arthritis Rheum. 1979;22:1361–1364. doi: 10.1002/art.1780221207. [DOI] [PubMed] [Google Scholar]
  • 38.Olecranon septic bursitis managed in an ambulatory setting. The Calgary Home Parenteral Therapy Program Study Group. Laupland KB, Davies HD. https://www.nlc-bnc.ca/eppp-archive/100/201/300/cdn_medical_association/cim/vol-24/issue-4/pdf/pg171.pdf. Clin Invest Med. 2001;24:171–178. [PubMed] [Google Scholar]
  • 39.Septic bursitis in immunocompromised patients. Roschmann RA, Bell CL. Am J Med. 1987;83:661–665. doi: 10.1016/0002-9343(87)90895-3. [DOI] [PubMed] [Google Scholar]
  • 40.Predisposing factors, bacteriology and antibiotic therapy in 35 cases of septic bursitis. Söderquist B, Hedström SA. Scand J Infect Dis. 1986;18:305–311. doi: 10.3109/00365548609032341. [DOI] [PubMed] [Google Scholar]
  • 41.Infectious olecranon and patellar bursitis: short-course adjuvant antibiotic therapy is not a risk factor for recurrence in adult hospitalized patients. Perez C, Huttner A, Assal M, Bernard L, Lew D, Hoffmeyer P, Uçkay I. J Antimicrob Chemother. 2010;65:1008–1014. doi: 10.1093/jac/dkq043. [DOI] [PubMed] [Google Scholar]
  • 42.A comparison between septic bursitis caused by Staphylococcus aureus and those caused by other organisms. Cea-Pereiro JC, Garcia-Meijide J, Mera-Varela A, Gomez-Reino JJ. Clin Rheumatol. 2001;20:10–14. doi: 10.1007/s100670170096. [DOI] [PubMed] [Google Scholar]
  • 43.Septic olecranon bursitis due to hematogenous infection with Streptococcus pneumoniae. Gleich S, Fomberstein B. https://europepmc.org/article/med/4087256. J Rheumatol. 1985;12:1018–1019. [PubMed] [Google Scholar]
  • 44.Septic bursitis. Zimmermann B, 3rd 3rd, Mikolich DJ, Ho G, Jr Jr. Semin Arthritis Rheum. 1995;24:391–410. doi: 10.1016/s0049-0172(95)80008-5. [DOI] [PubMed] [Google Scholar]
  • 45.Olecranon bursitis and bacteremia due to Serratia marcescens. Kahl LE, Rodnan GP. https://ohsu.pure.elsevier.com/en/publications/olecranon-bursitis-and-bacteremia-due-to-serratia-marcescens-2. J Rheumatol. 1984;11:402–403. [PubMed] [Google Scholar]
  • 46.Hemophilus influenzae bursitis and meningitis in an adult. Knisely GK, Gibson GR, Reichman RC. https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/603393. Arch Intern Med. 1983;143:1465–1466. [PubMed] [Google Scholar]
  • 47.Long-term follow-up of corticosteroid injection for traumatic olecranon bursitis. Weinstein PS, Canoso JJ, Wohlgethan JR. Ann Rheum Dis. 1984;43:44–46. doi: 10.1136/ard.43.1.44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Septic bursitis: a case report and primer for the emergency clinician. Wasserman AR, Melville LD, Birkhahn RH. J Emerg Med. 2009;37:269–272. doi: 10.1016/j.jemermed.2007.03.005. [DOI] [PubMed] [Google Scholar]
  • 49.Mycobacterium kansasii olecranon bursitis. Barham GS, Hargreaves DG. J Med Microbiol. 2006;55:1745–1746. doi: 10.1099/jmm.0.46795-0. [DOI] [PubMed] [Google Scholar]
  • 50.Olecranon bursitis. Reilly D, Kamineni S. J Shoulder Elbow Surg. 2016;25:158–167. doi: 10.1016/j.jse.2015.08.032. [DOI] [PubMed] [Google Scholar]
  • 51.Mycobacterium asiaticum as the probable causative agent in a case of olecranon bursitis. Dawson DJ, Blacklock ZM, Ashdown LR, Böttger EC. J Clin Microbiol. 1995;33:1042–1043. doi: 10.1128/jcm.33.4.1042-1043.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen. Achermann Y, Goldstein EJ, Coenye T, Shirtliff ME. Clin Microbiol Rev. 2014;27:419–440. doi: 10.1128/CMR.00092-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Cutibacterium acnes as an opportunistic pathogen: an update of its virulence-associated factors. Mayslich C, Grange PA, Dupin N. Microorganisms. 2021;9 doi: 10.3390/microorganisms9020303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Use of serum antistreptolysin O titers in the microbial diagnosis of orthopedic infections. Uçkay I, Ferry T, Stern R, et al. Int J Infect Dis. 2009;13:421–424. doi: 10.1016/j.ijid.2008.10.004. [DOI] [PubMed] [Google Scholar]
  • 55.Olecranon osteomyelitis caused by Mycobacterium chelonae. Hagiya H, Hayashi M, Katayama I, Tomono K. Intern Med. 2016;55:1825. doi: 10.2169/internalmedicine.55.6490. [DOI] [PubMed] [Google Scholar]
  • 56.Atypical mycobacterial osteomyelitis of the olecranon in an adult: a rare occurrence. Anshuman R, Rajnish RK, Verma NN, Jamshed M, Pandey R, Bhayana H. Int J Sci Res. 2018;7:47–49. [Google Scholar]
  • 57.Mycobacterium biofilms. Esteban J, García-Coca M. Front Microbiol. 2017;8:2651. doi: 10.3389/fmicb.2017.02651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Singularities of pyogenic Streptococcal biofilms - from formation to health implication. Alves-Barroco C, Paquete-Ferreira J, Santos-Silva T, Fernandes AR. Front Microbiol. 2020;11:584947. doi: 10.3389/fmicb.2020.584947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Physiology of mycobacteria. Cook GM, Berney M, Gebhard S, Heinemann M, Cox RA, Danilchanka O, Niederweis M. Adv Microb Physiol. 2009;55:81-182, 318-9. doi: 10.1016/S0065-2911(09)05502-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Culture-negative prosthetic joint infection. Berbari EF, Marculescu C, Sia I, et al. Clin Infect Dis. 2007;45:1113–1119. doi: 10.1086/522184. [DOI] [PubMed] [Google Scholar]
  • 61.Risk factors for deep infection after total knee arthroplasty: a meta-analysis. Chen J, Cui Y, Li X, Miao X, Wen Z, Xue Y, Tian J. Arch Orthop Trauma Surg. 2013;133:675–687. doi: 10.1007/s00402-013-1723-8. [DOI] [PubMed] [Google Scholar]
  • 62.Open debridement and prosthesis retention is a viable treatment option for acute periprosthetic joint infection after total knee arthroplasty. Koh IJ, Han SB, In Y, Oh KJ, Lee DH, Kim TK. Arch Orthop Trauma Surg. 2015;135:847–855. doi: 10.1007/s00402-015-2237-3. [DOI] [PubMed] [Google Scholar]
  • 63.Outcome of prosthetic joint infections treated with debridement and retention of components. Marculescu CE, Berbari EF, Hanssen AD, Steckelberg JM, Harmsen SW, Mandrekar JN, Osmon DR. Clin Infect Dis. 2006;42:471–478. doi: 10.1086/499234. [DOI] [PubMed] [Google Scholar]
  • 64.Cementless two-stage exchange arthroplasty for infection after total hip arthroplasty. Masri BA, Panagiotopoulos KP, Greidanus NV, Garbuz DS, Duncan CP. J Arthroplasty. 2007;22:72–78. doi: 10.1016/j.arth.2006.02.156. [DOI] [PubMed] [Google Scholar]
  • 65.Direct-exchange arthroplasty for the treatment of infection after total hip replacement. An average ten-year follow-up. Ure KJ, Amstutz HC, Nasser S, Schmalzried TP. J Bone Joint Surg Am. 1998;80:961–968. doi: 10.2106/00004623-199807000-00004. [DOI] [PubMed] [Google Scholar]
  • 66.Prolonged bacterial culture to identify late periprosthetic joint infection: a promising strategy. Schäfer P, Fink B, Sandow D, Margull A, Berger I, Frommelt L. Clin Infect Dis. 2008;47:1403–1409. doi: 10.1086/592973. [DOI] [PubMed] [Google Scholar]
  • 67.Propionibacterium in shoulder arthroplasty: what we think we know today. Hsu JE, Bumgarner RE, Matsen FA 3rd. J Bone Joint Surg Am. 2016;98:597–606. doi: 10.2106/JBJS.15.00568. [DOI] [PubMed] [Google Scholar]
  • 68.Propionibacterium acnes: disease-causing agent or common contaminant? Detection in diverse patient samples by next-generation sequencing. Mollerup S, Friis-Nielsen J, Vinner L, et al. J Clin Microbiol. 2016;54:980–987. doi: 10.1128/JCM.02723-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Neer Award 2017: a rapid method for detecting Propionibacterium acnes in surgical biopsy specimens from the shoulder. Holmes S, Pena Diaz AM, Athwal GS, Faber KJ, O'Gorman DB. J Shoulder Elbow Surg. 2017;26:179–185. doi: 10.1016/j.jse.2016.10.001. [DOI] [PubMed] [Google Scholar]
  • 70.Septic bursitis. Simonelli C, Zoschke D, Bankhurst A, Messner R. Ann Intern Med. 1978;89:575–576. doi: 10.7326/0003-4819-89-4-575_2. [DOI] [PubMed] [Google Scholar]
  • 71.Bone marrow mesenchymal stem cells offer an immune-privileged niche to Cutibacterium acnes in case of implant-associated osteomyelitis. Dubus M, Varin J, Papa S, et al. Acta Biomater. 2022;137:305–315. doi: 10.1016/j.actbio.2021.10.026. [DOI] [PubMed] [Google Scholar]
  • 72.Cutibacterium (formerly Propionibacterium) acnes clavicular infection. Zaid M, Chavez MR, Carrasco AE, et al. J Bone Jt Infect. 2019;4:40–49. doi: 10.7150/jbji.29153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Occult clavicle osteomyelitis caused by Cutibacterium acnes (C. acnes) after coracoclavicular ligament reconstruction: a case report and review of the literature. Washburn F, Tran B, Golden T. Int J Surg Case Rep. 2022;94:107114. doi: 10.1016/j.ijscr.2022.107114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Posterior elbow wounds: soft tissue coverage options and techniques. Patel KM, Higgins JP. Orthop Clin North Am. 2013;44:409-17, x. doi: 10.1016/j.ocl.2013.03.011. [DOI] [PubMed] [Google Scholar]
  • 75.Defect reconstruction over the olecranon with the distally extended lateral arm flap. Wettstein R, Helmy N, Kalbermatten DF. J Plast Reconstr Aesthet Surg. 2014;67:1125–1128. doi: 10.1016/j.bjps.2014.04.036. [DOI] [PubMed] [Google Scholar]
  • 76.Olecranon osteomyelitis due to Actinomyces meyeri: report of a culture-proven case. Kim JY, Kang EK, Moon SM, et al. Infect Chemother. 2016;48:234–238. doi: 10.3947/ic.2016.48.3.234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Osteomyelitis resulting from chronic septic olecranon bursitis: report of two cases. Moon M-S, Kim S-T, Park B-K. Clin Shoulder Elb. 2016;19:10. [Google Scholar]
  • 78.Cutibacterium acnes is an intracellular and intra-articular commensal of the human shoulder joint. Hudek R, Brobeil A, Brüggemann H, Sommer F, Gattenlöhner S, Gohlke F. J Shoulder Elbow Surg. 2021;30:16–26. doi: 10.1016/j.jse.2020.04.020. [DOI] [PubMed] [Google Scholar]
  • 79.Diphtheroid osteomyelitis. Morrey BF, Fitzgerald RH, Kelly PJ, Dobyns JH, Washington JA 2nd. https://journals.lww.com/jbjsjournal/Abstract/1977/59040/Diphtheroid_osteomyelitis.20.aspx. J Bone Joint Surg Am. 1977;59:527–530. [PubMed] [Google Scholar]
  • 80.Improving diagnostic criteria for Propionibacterium acnes osteomyelitis: a retrospective analysis. Asseray N, Papin C, Touchais S, et al. Scand J Infect Dis. 2010;42:421–425. doi: 10.3109/00365540903527330. [DOI] [PubMed] [Google Scholar]
  • 81.Propionibacterium acnes osteomyelitis: case report and review of the literature. Noble RC, Overman SB. J Clin Microbiol. 1987;25:251–254. doi: 10.1128/jcm.25.2.251-254.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Sliding motility in mycobacteria. Martínez A, Torello S, Kolter R. J Bacteriol. 1999;181:7331–7338. doi: 10.1128/jb.181.23.7331-7338.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Osteomyelitis and the role of biofilms in chronic infection. Brady RA, Leid JG, Calhoun JH, Costerton JW, Shirtliff ME. FEMS Immunol Med Microbiol. 2008;52:13–22. doi: 10.1111/j.1574-695X.2007.00357.x. [DOI] [PubMed] [Google Scholar]
  • 84.Momodu II, Savaliya V. StatPearls. Treasure Island: StatPearls Publishing; 2021. Osteomyelitis. [Google Scholar]
  • 85.Delayed Propionibacterium acnes surgical site infections occur only in the presence of an implant. Shiono Y, Ishii K, Nagai S, et al. Sci Rep. 2016;6:32758. doi: 10.1038/srep32758. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Ileopectineal bursitis following total hip replacement. Kolmert L, Persson BM, Herrlin K, Ekelund L. Acta Orthop Scand. 1984;55:63–65. doi: 10.3109/17453678408992314. [DOI] [PubMed] [Google Scholar]
  • 87.Prepatellar and olecranon bursitis: literature review and development of a treatment algorithm. Baumbach SF, Lobo CM, Badyine I, Mutschler W, Kanz KG. Arch Orthop Trauma Surg. 2014;134:359–370. doi: 10.1007/s00402-013-1882-7. [DOI] [PubMed] [Google Scholar]
  • 88.Septic bursitis in the prepatellar and olecranon bursae: an analysis of 25 cases. Ho G Jr, Tice AD, Kaplan SR. Ann Intern Med. 1978;89:21–27. doi: 10.7326/0003-4819-89-1-21. [DOI] [PubMed] [Google Scholar]
  • 89.Wound healing and infection in surgery: the pathophysiological impact of smoking, smoking cessation, and nicotine replacement therapy: a systematic review. Sørensen LT. Ann Surg. 2012;255:1069–1079. doi: 10.1097/SLA.0b013e31824f632d. [DOI] [PubMed] [Google Scholar]
  • 90.Septic olecranon bursitis in patients with chronic obstructive pulmonary disease. Enzenauer RJ, Pluss JL. Am J Med. 1996;100:479–480. doi: 10.1016/s0002-9343(97)89529-0. [DOI] [PubMed] [Google Scholar]
  • 91.Biofilm formation by Propionibacterium acnes on biomaterials in vitro and in vivo: impact on diagnosis and treatment. Bayston R, Ashraf W, Barker-Davies R, et al. J Biomed Mater Res A. 2007;81:705–709. doi: 10.1002/jbm.a.31145. [DOI] [PubMed] [Google Scholar]

Articles from Cureus are provided here courtesy of Cureus Inc.

RESOURCES